Elaine M. Gabovitch, MPA, an autism advocate at UMass Medical School’s Eunice Kennedy Shriver Center, will train health professionals to consider cultural diversity when screening young children for autism spectrum disorder (ASD) during a session at the Association of Maternal & Child Health Programs (AMCHP) annual conference Jan. 24 in Washington, D.C.
Who We Are
The Eunice Kennedy Shriver Center at UMass Medical School has a rich history of supporting research, education, and service aimed at improving the quality of life for persons with intellectual and developmental disabilities (IDD) and their families.
Our research covers a wide range of topics related to IDD. We create and deliver training programs that teach and train those who want to enhance the lives of people with disabilities. We develop and provide a range of information and resources to individuals with IDD and autism spectrum disorder and their families – plus clinicians, educators, and human services agencies.
We look forward to working with you.
Participate in a Study?
Do you want to make a difference in the lives of people with intellectual and developmental disabilities? Please consider participating in one of our research studies!
The Shriver Center has been a pioneer in research, education and service for individuals with IDD and their families. To that end, we are always looking for children and young adults—with or without disabilities—to take part in our research programs.
UMass Medical School is one of two American universities to serve as a host institution for a European-Union-funded research program focused on developing new technologies to help individuals with autism spectrum disorders and intellectual disability.
The Eunice Kennedy Shriver Center, a unit of UMass Medical School’s Commonwealth Medicine division, is partnering with the European Union Marie Curie ASSISTID (Assistive Technologies for People with Autism and Intellectual Disability) Cofund program on the recently launched project. The program, which has committed $12 million over the next five years, is co-funded by the EU's European Commission and the DOCTRID (Daughters of Charity-Technology, Research into Disability) Research Institute in Ireland.